1
24 Poster abstracts / Reproductive Toxicology 41 (2013) 21–34 Teratogenic effects of mixtures of azole fungicides assessed in vitro and in vivo: II – Binary mixtures with increasing levels of one of the two components Francesca Di Renzo 1,, Angelo Moretto 2,3 , Elena Menegola 1 1 Università degli Studi di Milano, Department of Biosciences, Milano, Italy 2 International Centre for Pesticides and Health Risk Prevention (ICPS) University Hospital Luigi Sacco, Milano, Italy 3 Università degli Studi di Milano, Department of Occupational and Environmental Health, Milano, Italy On the basis of results obtained by co-exposure to “similar potency levels” of the agrochemical fungicides triadimefon (FON) and flusilazole (FLUSI), and to better characterize the contribu- tion of each component to the observed effects, with the present work the in vitro and in vivo teratogenicity of co-exposures to variable combinations of compounds has been evaluated. Embryos were exposed to the No Observed Effect Level (NOEL) of one azole (“fixed”) and increasing levels of the other selected azole (“mov- ing”). The final aim was to compare the dose–response curve of the “moving” molecule alone or in the presence of a non-effective level of a molecule with a suspected same mode of action. In vitro protocol: E9.5 CD rat embryos were cultured for 48 h in presence of solvent alone (ethanol) or in presence of FON (6.25–50 M), FLUSI (1.56–12.5 M) or mixtures of FON (6.25 M) + FLUSI (1.56–3.125–6.25 M) or FLUSI (1.56 M) + FON (6.25–12.5–25 M). At the end of the culture period, embryos were morphologically examined. A clear concentration–response was observed both for the single fungicides and for mixtures. The observed malformations were specifically at the level of the branchial apparatus (reduction and fusion of branchial arches). The co-exposure caused a shift of concentration–response curve in both cases. In vivo protocol: E8 CD1 mouse females were treated by gavage with the solvent alone (acetone:corn oil 1:9) or in pres- ence of FON (75–300 mg/kg), FLUSI (37.5 mg/kg) or mixtures of FLUSI (37.5 mg/kg) + FON (75–225 mg/kg). Fetuses were examined at term of gestation for external abnormalities. The specific mal- formation observed at term of gestation was palatoschisis. A clear concentration–response was observed both for the single fungi- cides and for mixtures. The data obtained after in vitro and in vivo exposure sug- gest that the basal low level of one azole residue could shift the dose–response curve of the “moving” fungicide, supporting the additive effects of the co-exposure to azole fungicides for mam- malian developing embryos. Our results, therefore, suggest that azoles causing this effect should be grouped together for risk assess- ment. http://dx.doi.org/10.1016/j.reprotox.2013.06.039 Relevance of kinetics and histopathology as part of the embry- onic zebrafish screening test André Wolterbeek, Vera van der Weijden, CorSnel, Anna Beker, Didima de Groot, Aswin Menke TNO, Zeist, The Netherlands Growing awareness to apply the principles of Replacement, Refinement and Reduction (3Rs) of animals in regulatory testing drives the need for alternatives identifying potential toxic agents with accuracy, speed, reliability and respect for animal welfare. So far, for complex endpoints like reproduction and develop- mental toxicology, animal-free in vitro models are limited and cover only a restricted part of the reproductive cycle. Various characteristics warrant Zebrafish (embryos and/or larvae) an ideal non-mammalian whole organism model that could bridge gaps between in vitro cell systems and complex reproduction studies in mammals, e.g. small size, ease of obtaining high number of progeny, external fertilization, transparency and rapid develop- ment of embryo, and a basic understanding of its gene function and physiology. Our research shows that morphological examination of zebrafish embryos/larvae, predicts toxicity of chemical and phar- maceutical agents with high certainty and proves to form a reliable total organism approach to study embryo- and developmental (neuro)toxicity. A full histopathological survey of the embryo’s combined with high-end analytical methods appears to further increase the applicability domain of the zebrafish in toxicity screening studies. Further refinement with respect to the physical and chemical properties of test compounds determining the body burden and tissue distribution, increases the predictability of the assay. http://dx.doi.org/10.1016/j.reprotox.2013.06.040 Renal and skeletal hypoplasia in mouse fetuses following mater- nal exposure to aflatoxin B1 during gestation Yousef M. Abdulrazzaq 1 , Rengasamy Padmanabhan 2 , Salim A. Bastaki 3 , Jose Kochiyil 1 , Mohamed Shafiullah 3 1 Department of Paediatrics, Faculty of Medicine and Health Sciences, UAE University, PO Box 17666, Al Ain, United Arab Emirates 2 Division of Basic Medical Sciences, School of Medicine, Mercer Uni- versity, Macon, GA, USA 3 Department of Pharmacology, Faculty of Medicine and Health Sci- ences, UAE University, PO Box 17666, Al Ain, United Arab Emirates There is a paucity of information on the reproductive toxic effects of aflatoxins and the data in the literature are largely based on poorly described methodology. Our aim was to evaluate the consequences of aflatoxin B1 (AFB1) administered during early and late stages of organogenesis on fetal growth and development in the mouse. We administered groups of mice a single dose of 20 mg/kg AFB1 dissolved in DMSO either intraperitoneally (IP) or orally on gestation days (GD) 7, or 13. The controls received a pro- portionate volume of DMSO. Fetuses were collected on GD 18. This treatment was found to be maternally non-toxic. However AFB1- treatment resulted in significantly increased incidence of fetuses with intrauterine growth restriction (IUGR) weighing 2 or more standard deviations (SD) less than the mean of the controls. A sig- nificant number of fetuses of AFB1-treated mice also were found to have developed hypoplastic kidneys. The AFB1 group fetuses also had delay in ossification and maturity of the supraoccipital bone development, cervical and coccygeal vertebral bodies, and the bones of the fore and hind paws. Another major finding was the increased incidence of minor malformations, such as the presence of cervical ribs and sternal anomalies. The results of this study show that the late organogenesis stage of development is particularly susceptible to the deleterious effects AFB1 in mice. Keywords: Aflatoxin; Mouse; Fetal skeletal hypoplasia; Intrauterine growth restriction; Hypoplastic kidneys. http://dx.doi.org/10.1016/j.reprotox.2013.06.041

Relevance of kinetics and histopathology as part of the embryonic zebrafish screening test

  • Upload
    aswin

  • View
    215

  • Download
    1

Embed Size (px)

Citation preview

Page 1: Relevance of kinetics and histopathology as part of the embryonic zebrafish screening test

24 Poster abstracts / Reproductive Toxicology 41 (2013) 21–34

Teratogenic effects of mixtures of azole fungicides assessedin vitro and in vivo: II – Binary mixtures with increasing levelsof one of the two components

Francesca Di Renzo 1,∗, Angelo Moretto 2,3, Elena Menegola 1

1 Università degli Studi di Milano, Department of Biosciences, Milano,Italy2 International Centre for Pesticides and Health Risk Prevention (ICPS)University Hospital Luigi Sacco, Milano, Italy3 Università degli Studi di Milano, Department of Occupational andEnvironmental Health, Milano, Italy

On the basis of results obtained by co-exposure to “similarpotency levels” of the agrochemical fungicides triadimefon (FON)and flusilazole (FLUSI), and to better characterize the contribu-tion of each component to the observed effects, with the presentwork the in vitro and in vivo teratogenicity of co-exposures tovariable combinations of compounds has been evaluated. Embryoswere exposed to the No Observed Effect Level (NOEL) of one azole(“fixed”) and increasing levels of the other selected azole (“mov-ing”). The final aim was to compare the dose–response curve of the“moving” molecule alone or in the presence of a non-effective levelof a molecule with a suspected same mode of action.

In vitro protocol: E9.5 CD rat embryos were cultured for48 h in presence of solvent alone (ethanol) or in presence ofFON (6.25–50 �M), FLUSI (1.56–12.5 �M) or mixtures of FON(6.25 �M) + FLUSI (1.56–3.125–6.25 �M) or FLUSI (1.56 �M) + FON(6.25–12.5–25 �M). At the end of the culture period, embryoswere morphologically examined. A clear concentration–responsewas observed both for the single fungicides and for mixtures.The observed malformations were specifically at the level of thebranchial apparatus (reduction and fusion of branchial arches). Theco-exposure caused a shift of concentration–response curve in bothcases.

In vivo protocol: E8 CD1 mouse females were treated bygavage with the solvent alone (acetone:corn oil 1:9) or in pres-ence of FON (75–300 mg/kg), FLUSI (37.5 mg/kg) or mixtures ofFLUSI (37.5 mg/kg) + FON (75–225 mg/kg). Fetuses were examinedat term of gestation for external abnormalities. The specific mal-formation observed at term of gestation was palatoschisis. A clearconcentration–response was observed both for the single fungi-cides and for mixtures.

The data obtained after in vitro and in vivo exposure sug-gest that the basal low level of one azole residue could shift thedose–response curve of the “moving” fungicide, supporting theadditive effects of the co-exposure to azole fungicides for mam-malian developing embryos. Our results, therefore, suggest thatazoles causing this effect should be grouped together for risk assess-ment.

http://dx.doi.org/10.1016/j.reprotox.2013.06.039

Relevance of kinetics and histopathology as part of the embry-onic zebrafish screening test

André Wolterbeek, Vera van der Weijden, CorSnel, Anna Beker,Didima de Groot, Aswin Menke

TNO, Zeist, The Netherlands

Growing awareness to apply the principles of Replacement,Refinement and Reduction (3Rs) of animals in regulatory testingdrives the need for alternatives identifying potential toxic agentswith accuracy, speed, reliability and respect for animal welfare.So far, for complex endpoints like reproduction and develop-mental toxicology, animal-free in vitro models are limited andcover only a restricted part of the reproductive cycle. Various

characteristics warrant Zebrafish (embryos and/or larvae) an idealnon-mammalian whole organism model that could bridge gapsbetween in vitro cell systems and complex reproduction studiesin mammals, e.g. small size, ease of obtaining high number ofprogeny, external fertilization, transparency and rapid develop-ment of embryo, and a basic understanding of its gene functionand physiology.

Our research shows that morphological examination ofzebrafish embryos/larvae, predicts toxicity of chemical and phar-maceutical agents with high certainty and proves to form a reliabletotal organism approach to study embryo- and developmental(neuro)toxicity. A full histopathological survey of the embryo’scombined with high-end analytical methods appears to furtherincrease the applicability domain of the zebrafish in toxicityscreening studies. Further refinement with respect to the physicaland chemical properties of test compounds determining the bodyburden and tissue distribution, increases the predictability of theassay.

http://dx.doi.org/10.1016/j.reprotox.2013.06.040

Renal and skeletal hypoplasia in mouse fetuses following mater-nal exposure to aflatoxin B1 during gestation

Yousef M. Abdulrazzaq 1, Rengasamy Padmanabhan 2, Salim A.Bastaki 3, Jose Kochiyil 1, Mohamed Shafiullah 3

1 Department of Paediatrics, Faculty of Medicine and Health Sciences,UAE University, PO Box 17666, Al Ain, United Arab Emirates2 Division of Basic Medical Sciences, School of Medicine, Mercer Uni-versity, Macon, GA, USA3 Department of Pharmacology, Faculty of Medicine and Health Sci-ences, UAE University, PO Box 17666, Al Ain, United Arab Emirates

There is a paucity of information on the reproductive toxiceffects of aflatoxins and the data in the literature are largely basedon poorly described methodology. Our aim was to evaluate theconsequences of aflatoxin B1 (AFB1) administered during earlyand late stages of organogenesis on fetal growth and developmentin the mouse. We administered groups of mice a single dose of20 mg/kg AFB1 dissolved in DMSO either intraperitoneally (IP) ororally on gestation days (GD) 7, or 13. The controls received a pro-portionate volume of DMSO. Fetuses were collected on GD 18. Thistreatment was found to be maternally non-toxic. However AFB1-treatment resulted in significantly increased incidence of fetuseswith intrauterine growth restriction (IUGR) weighing 2 or morestandard deviations (SD) less than the mean of the controls. A sig-nificant number of fetuses of AFB1-treated mice also were foundto have developed hypoplastic kidneys. The AFB1 group fetusesalso had delay in ossification and maturity of the supraoccipitalbone development, cervical and coccygeal vertebral bodies, and thebones of the fore and hind paws. Another major finding was theincreased incidence of minor malformations, such as the presenceof cervical ribs and sternal anomalies. The results of this study showthat the late organogenesis stage of development is particularlysusceptible to the deleterious effects AFB1 in mice.

Keywords: Aflatoxin; Mouse; Fetal skeletal hypoplasia;Intrauterine growth restriction; Hypoplastic kidneys.

http://dx.doi.org/10.1016/j.reprotox.2013.06.041